Conditions: Infertility
Keywords: In vitro fertilization (IVF) Assisted reproduction technologies (ART) GnRH-antagonist Follicle stimulating hormone (FSH)
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 710
Healthy volunteers: no

Brief summary:
The purpose of the non-inferiority study is to evaluate the clinical efficacy and the safety of two different subcutaneous FSH preparations (Fostimon versus Gonal-F) for controlled ovarian hyperstimulation in a GnRH-antagonist cycle.

Detailed description:

Arms:
arm 1: 75 IU/vial, powder and solvent for solution for subcutaneous injection (Follicle Stimulating Hormone,IBSA Institut Biochimique SA) arm 2: 75 IU/vial powder and solvent for solution for subcutaneous injection (Follicle Stimulating Hormone; Merck Serono)

Interventions: intervention 1: Urofollitrophin intervention 2: Follitrophin alpha
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: